MedTrace Logo

Cervical Cancer Screening in HIV Positive and Negative Women in Cambodia

NCT02253719 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2015-10-07

No results posted yet for this study

Summary

The prevalence of cervical neoplasia in Cambodia is not known. There are no screening programs in place. The investigators plan on introducing a screening program based on WHO criteria and utilizing visualization with acetic acid. Patients who are positive will be offered same-day cryotherapy if indicated or will be referred for biopsy, LEEP and hysterectomy as indicated. The planned patient pool for this study is 1000 women, half of whom will be HIV positive (and thus have a presumed higher incidence of cervical neoplasia).

Conditions

Interventions

PROCEDURE

cryotherapy, further biopsy, LEEP, surgery as indicated

These interventions and their outcomes are not part of this study. However, we will be offering at no charge appropriate treatment for neoplasia or cancer that is diagnosed.

Sponsors & Collaborators

  • Sihanouk Hospital Center of HOPE

    lead OTHER

Principal Investigators

  • Thay Sovanarra, MD · Sihanouk Hospital

Eligibility

Min Age
30 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2015-09-30
Completion
2015-09-30

Countries

  • Cambodia

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02253719 on ClinicalTrials.gov